---
company: Baldwin Insurance Group, Inc.
ticker: BWIN
form: 8-K
filed: 2026-07-30
accession: 0001781755-26-000047
source: https://www.sec.gov/Archives/edgar/data/1781755/000178175526000047/
---

# Baldwin Insurance Group (BWIN) earnings release, July 30, 2026

Baldwin Insurance Group, Inc. (BWIN) · Form 8-K, Item 2.02 · Filed 2026-07-30 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1781755/000178175526000047/)

THE BALDWIN GROUP ANNOUNCES SECOND QUARTER 2026 RESULTS — Second Quarter Total Revenue Growth of 30% to $492.9 Million — — Second Quarter Net Loss of $56.0 Million; Adjusted EBITDA

(1)

Growth of 37% to $116.7 Million — — Second Quarter Diluted Loss Per Share of $0.42; Adjusted Diluted EPS

(2) of $0.48 — — Second Quarter Net Loss Margin of 11%; Adjusted EBITDA Margin

(1) of 24% — — Second Quarter Net Cash Provided by Operating Activities of $45.6 Million; Adjusted Free Cash Flow

(3)

Increased 437% to $46.4 Million — — Year-to-Date Net Cash Provided by Operating Activities of $39.5 Million; Adjusted Free Cash Flow Increased 34% to $46.2 Million — TAMPA, FLORIDA - July 30, 2026 - The Baldwin Group, the brand name for The Baldwin Insurance Group, Inc. (“Baldwin” or the “Company”) (NASDAQ: BWIN), an independent insurance distribution firm delivering tailored insurance solutions to a wide range of personal and commercial clients, today announced its results for the second quarter ended June 30, 2026.

SECOND QUARTER 2026 HIGHLIGHTS

• Total revenue increased 30% year-over-year to $492.9 million

• Organic revenue growth

(4) of 2% year-over-year

• CAC Group total revenue growth

(5) of 23% year-over-year

• GAAP net loss of $56.0 million and GAAP diluted loss per share of $0.42

• Adjusted net income

(2) of $68.5 million

• Adjusted diluted EPS increased 14% year-over-year to $0.48

• Adjusted EBITDA grew 37% to $116.7 million

• Net loss margin of 11%

• Adjusted EBITDA margin of 23.7%, a 110 basis point expansion compared to 22.6% in the prior-year period

• Net cash provided by operating activities of $45.6 million

• Adjusted free cash flow increased 437% year-over-year to $46.4 million¹

“We are thrilled with our momentum as reflected in our strong second quarter results. Total revenue grew 30% to $492.9 million, adjusted EBITDA grew 37% to $116.7 million, and adjusted free cash flow increased 437% to $46.4 million,” said Trevor Baldwin, Chief Executive Officer of The Baldwin Group. “As we previously highlighted, we have largely lapped the idiosyncratic, one-time headwinds that we believe will transition into tailwinds for our business in the back half of 2026. When combined with the strong contribution from our recent partnerships, we continue to win market share at an outsized rate, evidenced by sales velocity of 30% in our combined IAS business and normalized organic growth of 8%. This is a testament to the depth of expertise, value delivered to clients, and commitment from our dedicated colleagues.”

Baldwin added, “We remain excited for the opportunities we have ahead of us and what we can achieve in the coming year for shareholders, clients and colleagues.”

LIQUIDITY AND CAPITAL RESOURCES

As of June 30, 2026, cash and cash equivalents were $184.5 million and the Company had $259.4 million of borrowing capacity under its revolving credit facility.

SIX MONTHS 2026 RESULTS

• Revenue increased 29% year-over-year to $1.0 billion

• Organic revenue growth of 2% year-over-year

• CAC Group total revenue growth of 25% year-over-year

• GAAP net loss of $57.9 million and GAAP diluted loss per share of $0.39

• Adjusted net income of $157.8 million

• Adjusted diluted EPS grew 5% year-over-year to $1.11

• Adjusted EBITDA grew 27% year-over-year to $254.0 million

• Net loss margin of 6%

• Adjusted EBITDA margin was 24.8% compared to 25.2% in the prior-year period

• Net cash provided by operating activities of $39.5 million

• Adjusted free cash flow increased 34% year-over-year to $46.2 million

WEBCAST AND CONFERENCE CALL INFORMATION

Baldwin will host a live audio webcast today at 5:00 PM Eastern Time to discuss the Company’s second quarter 2026 performance, including management’s perspectives on the business. The live audio webcast will be accessible via Baldwin’s investor relations website at ir.baldwin.com and a replay of the webcast will be available at ir.baldwin.com for approximately one year.²

ABOUT THE BALDWIN GROUP

The Baldwin Group, the brand name for The Baldwin Insurance Group, Inc. ("Baldwin") (NASDAQ: BWIN) and its affiliates, is an independent insurance distribution firm providing indispensable expertise and insights that strive to give our clients the confidence to pursue their purpose, passion and dreams. As a team of dedicated entrepreneurs and insurance professionals, we have come together to help protect the possible for our clients. We do this by delivering bespoke client solutions, services, and innovation through our comprehensive and tailored approach to risk management, insurance, and employee benefits. We support our clients, colleagues, insurance company partners, and communities through the deployment of vanguard resources and capital to drive our organic and inorganic growth. The Baldwin Group proudly represents more than three million clients across the United States and internationally. For more information, please visit www.baldwin.com.

FOOTNOTES

(1) Adjusted EBITDA and adjusted EBITDA margin are non-GAAP measures. Reconciliation of adjusted EBITDA and adjusted EBITDA margin to net income (loss), the most directly comparable GAAP financial measure, is set forth in the reconciliation table accompanying this release.

(2) Adjusted net income and adjusted diluted EPS are non-GAAP measures. Reconciliation of adjusted net income to net income attributable to Baldwin and reconciliation of adjusted diluted EPS to diluted earnings (loss) per share, the most directly comparable GAAP financial measures, is set forth in the reconciliation table accompanying this release.

(3)

Adjusted free cash flow is a non-GAAP measure. Reconciliation of adjusted free cash flow to net cash provided by (used in) operating activities, the most directly comparable GAAP financial measure, is set forth in the reconciliation table accompanying this release.... (truncated)e three and six months ended June 30, 2026 was $376.3 million and $786.8 million, respectively, which is adjusted to exclude commissions and fees from divestitures that occurred during 2025. Organic revenue is also adjusted to exclude the first 12 months of commissions and fees generated from new partners during the three and six months ended June 30, 2026. Organic revenue and organic revenue growth are non-GAAP measures. Reconciliation of organic revenue and organic revenue growth to commissions and fees, the most directly comparable GAAP financial measure, is set forth in the reconciliation table accompanying this release.

(5) CAC Group total revenue growth is calculated as standalone CAC Group GAAP revenue for the three and six months ended June 30, 2026 compared to CAC Group GAAP revenue for the three and six months ended June 30, 2025.

NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release may contain various “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, which represent Baldwin’s expectations or beliefs concerning future events. Forward-looking statements are statements other than historical facts and may include statements that address Baldwin's future operating, financial or business performance or Baldwin’s strategies or expectations. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “potential,” “outlook” or “continue,” or the negative of these terms or other comparable terminology. Forward-looking statements are based on management’s current expectations and beliefs and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements.³

Factors that could cause actual results or performance to differ from the expectations expressed or implied in such forward-looking statements include, but are not limited to, those described under the caption “Risk Factors” in Baldwin’s Annual Report on Form 10-K for the year ended December 31, 2025 and in Baldwin’s other filings with the SEC, which are available free of charge on the SEC's website at: www.sec.gov, including those risks and other factors relevant to Baldwin's business, financial condition and results of operations. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated. All forward-looking statements and all subsequent written and oral forward-looking statements attributable to Baldwin or to persons acting on Baldwin's behalf are expressly qualified in their entirety by reference to these risks and uncertainties. You should not place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date they are made, and Baldwin does not undertake any obligation to update them in light of new information, future developments or otherwise, except as may be required under applicable law.

CONTACTS

MEDIA RELATIONS

Anna Rozenich, Senior Director, Enterprise Communications

The Baldwin Group

630.561.5907 | anna.rozenich@baldwin.com

INVESTOR RELATIONS

Bonnie Bishop, Executive Director, Investor Relations

The Baldwin Group

813.259.8032 |

IR@baldwin.com⁴

THE BALDWIN INSURANCE GROUP, INC.

Condensed Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)⁵

THE BALDWIN INSURANCE GROUP, INC.

Condensed Consolidated Balance Sheets

(Unaudited)⁶

THE BALDWIN INSURANCE GROUP, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited)⁷

NON-GAAP FINANCIAL MEASURES

Adjusted EBITDA, adjusted EBITDA margin, organic revenue, organic revenue growth, adjusted net income, adjusted diluted earnings per share (“EPS”), and adjusted net cash provided by operating activities (“adjusted free cash flow”) are not measures of financial performance under GAAP and should not be considered substitutes for GAAP measures, including commissions and fees (for organic revenue and organic revenue growth), net income (loss) (for adjusted EBITDA and adjusted EBITDA margin), net income (loss) attributable to Baldwin (for adjusted net income), diluted earnings (loss) per share (for adjusted diluted EPS) or net cash provided by (used in) operating activities (for adjusted free cash flow), which we consider to be the most directly comparable GAAP measures. These non-GAAP financial measures have limitations as analytical tools, and when assessing our operating performance, you should not consider these non-GAAP financial measures in isolation or as substitutes for commissions and fees, net income (loss), net income (loss) attributable to Baldwin, diluted earnings (loss) per share, net cash provided by (used in) operating activities or other consolidated income statement data prepared in accordance with GAAP. Other companies in our industry may define or calculate these non-GAAP financial measures differently than we do, and accordingly, these measures may not be comparable to similarly titled measures used by other companies.

We define adjusted EBITDA as net income (loss) before interest, taxes, depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related partnership and integration expenses, transformation costs, severance, and certain non-recurring items, including those related to raising capital. We believe that adjusted EBITDA is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance, and that the presentation of this measure enhances an investor’s understanding of our financial performance.... (truncated)DA margin is a key metric used by management and our board of directors to assess our financial performance. We believe that adjusted EBITDA margin is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance, and that the presentation of this measure enhances an investor’s understanding of our financial performance. We believe that adjusted EBITDA margin is helpful in measuring profitability of operations on a consolidated level.

Adjusted EBITDA and adjusted EBITDA margin have important limitations as analytical tools. For example, adjusted EBITDA and adjusted EBITDA margin:

• do not reflect any cash capital expenditure requirements for the assets being depreciated and amortized that may have to be replaced in the future;

• do not reflect changes in, or cash requirements for, our working capital needs;

• do not reflect the impact of certain cash charges resulting from matters we consider not to be indicative of our ongoing operations;

• do not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our debt;

• do not reflect share-based compensation expense and other non-cash charges; and

• exclude certain tax payments that may represent a reduction in cash available to us.⁸

We calculate organic revenue based on commissions and fees for the relevant period by excluding (i) the first 12 months of commissions and fees generated from new partners and (ii) commissions and fees from divestitures. Organic revenue growth is the change in organic revenue period-to-period, with prior period results adjusted to (i) include commissions and fees that were excluded from organic revenue in the prior period because the relevant partners had not yet reached the 12-month owned mark, but which have reached the 12-month owned mark in the current period, and (ii) exclude commissions and fees related to divestitures from organic revenue. For example, commissions and fees from a partner acquired on June 1, 2025 are excluded from organic revenue for 2025. However, after June 1, 2026, results from June 1, 2025 to December 31, 2025 for such partners are compared to results from June 1, 2026 to December 31, 2026 for purposes of calculating organic revenue growth in 2026. Organic revenue growth is a key metric used by management and our board of directors to assess our financial performance. We believe that organic revenue and organic revenue growth are appropriate measures of operating performance as they allow investors to measure, analyze and compare growth in a meaningful and consistent manner.

We define adjusted net income as net income (loss) attributable to Baldwin adjusted for depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related partnership and integration expenses, transformation costs, severance, and certain non-recurring costs that, in the opinion of management, significantly affect the period-over-period assessment of operating results, and the related tax effect of those adjustments. We believe that adjusted net income is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance.

Adjusted diluted EPS measures our per share earnings excluding certain expenses as discussed above for adjusted net income and assuming all shares of Class B common stock were exchanged for Class A common stock on a one-for-one basis. Adjusted diluted EPS is calculated as adjusted net income divided by adjusted diluted weighted-average shares outstanding. We believe adjusted diluted EPS is useful to investors because it enables them to better evaluate per share operating performance across reporting periods.

We calculate adjusted free cash flow because we incur substantial earnout liabilities in conjunction with our partnership strategy. Adjusted free cash flow is calculated as net cash provided by (used in) operating activities excluding the impact of: (i) the payment of contingent earnout consideration in excess of purchase price accrual, and (ii) the payment of colleague earnout incentives. We believe that adjusted free cash flow is an important measure of our ability to generate cash from our business operations.

Reconciliation of guidance regarding adjusted EBITDA, organic revenue growth and adjusted diluted EPS to the most directly comparable GAAP measures is not available without unreasonable efforts on a forward-looking basis due to the high variability, complexity, and low visibility with respect to commissions and fees, net income (loss), diluted earnings (loss) per share or other consolidated income statement data prepared in accordance with GAAP. The Company is currently unable to predict with a reasonable degree of certainty the type and extent of items that would be expected to impact these GAAP financial measures for these periods. The unavailable information could have a significant impact on the non-GAAP measures.⁹

Adjusted EBITDA and Adjusted EBITDA Margin

The following table reconciles adjusted EBITDA and adjusted EBITDA margin to net income (loss), which we consider to be the most directly comparable GAAP financial measure:

__________

(1) Interest expense, net does not include interest income on surplus notes.

(2) Income and other taxes include income tax expense/benefit, Tax Receivable Agreement expense and other operating tax expense, such as state taxes, under GAAP.

(3) Transformation costs represent certain non-recurring colleague compensation and technology-related expenses related to our $3B/30 Catalyst Program, which is designed to accelerate the infusion of automation, business process optimization and artificial intelligence to transform and elevate our workforce and unlock new avenues for growth.... (truncated) EBITDA include certain income and expenses that are considered to be non-recurring or non-operational, including certain recruiting costs, professional fees, litigation costs and bonuses.¹⁰

Organic Revenue and Organic Revenue Growth

The following table reconciles organic revenue and organic revenue growth to commissions and fees, which we consider to be the most directly comparable GAAP financial measure:

__________

(1) Includes the first 12 months of such commissions and fees generated from newly acquired partners.

(2) Organic revenue for the three and six months ended June 30, 2025 used to calculate organic revenue growth for the three and six months ended June 30, 2026 was $376.3 million and

$786.8 million, respectively, which is adjusted to exclude commissions and fees from divestitures that occurred during 2025.¹¹

Adjusted Net Income and Adjusted Diluted EPS

The following table reconciles adjusted net income to net income attributable to Baldwin and reconciles adjusted diluted EPS to diluted earnings (loss) per share, which we consider to be the most directly comparable GAAP financial measures:

___________

(1) Income tax expense includes income tax expense/benefit and Tax Receivable Agreement expense.

(2) Transformation costs represent certain non-recurring colleague compensation and technology-related expenses related to our $3B/30 Catalyst Program, which is designed to accelerate the infusion of automation, business process optimization and artificial intelligence to transform and elevate our workforce and unlock new avenues for growth.

(3) Other addbacks to adjusted net income include certain income and expenses that are considered to be non-recurring or non-operational, including certain recruiting costs, professional fees, litigation costs and bonuses.

(4) Represents corporate income taxes at an assumed effective tax rate of 9.9% applied to adjusted pre-tax income.

(5) Assumes the full exchange of Class B common stock for Class A common stock pursuant to the Amended LLC Agreement.¹²

Adjusted Net Cash Provided by Operating Activities (“Adjusted Free Cash Flow”)

The following table reconciles adjusted free cash flow to net cash provided by (used in) operating activities, which we consider to be the most directly comparable GAAP financial measure:¹³

COMMONLY USED DEFINED TERMS

The following terms have the following meanings throughout this press release unless the context indicates or requires otherwise:¹⁴

## Financial statements

### Income Statement (For the Three Months Ended June 30, — (Unaudited) (in thousands, except per share data))

| | For the Three Months Ended June 30, – 2026 | For the Three Months Ended June 30, – 2025 | For the Six Months Ended June 30, – 2026 | For the Six Months Ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| Commissions and fees | 488,789 | 376,249 | 1,017,650 | 786,780 |
| Investment income | 4,150 | 2,562 | 7,524 | 5,436 |
| Total revenues | 492,939 | 378,811 | 1,025,174 | 792,216 |
| Operating expenses: | Colleague compensation and benefits | 264,323 | 195,471 | 547,935 | 393,491 |
| Operating expenses: | Outside commissions | 71,798 | 73,586 | 138,477 | 139,409 |
| Operating expenses: | Other operating expenses | 94,058 | 56,119 | 318,221 | 114,138 |
| Operating expenses: | Amortization expense | 56,027 | 26,010 | 111,074 | 51,892 |
| Operating expenses: | Change in fair value of contingent consideration | 12,303 | -1,957 | 14,272 | 6,104 |
| Operating expenses: | Depreciation expense | 2,773 | 1,642 | 4,804 | 3,225 |
| Operating expenses: | Total operating expenses | 501,282 | 350,871 | 1,134,783 | 708,259 |
| Operating expenses: | Operating income (loss) | -8,343 | 27,940 | -109,609 | 83,957 |
| Other income (expense): | Interest expense, net | -45,666 | -31,320 | -84,566 | -61,296 |
| Other income (expense): | Gain (loss) on divestitures |  | -1,111 |  | 290 |
| Other income (expense): | Loss on extinguishment and modification of debt | -129 |  | -7,538 | -2,394 |
| Other income (expense): | Other income (expense), net | -2,423 | 35 | -1,776 | -115 |
| Other income (expense): | Total other expense, net | -48,218 | -32,396 | -93,880 | -63,515 |
| Other income (expense): | Income (loss) before income taxes and share of net earnings of equity method investee | -56,561 | -4,456 | -203,489 | 20,442 |
| Other income (expense): | Share of net earnings of equity method investee | 664 |  | 1,175 |  |
| Other income (expense): | Income (loss) before income taxes | -55,897 | -4,456 | -202,314 | 20,442 |
| Other income (expense): | Less: income tax expense (benefit) | 84 | 685 | -144,437 | 685 |
| Other income (expense): | Net income (loss) | -55,981 | -5,141 | -57,877 | 19,757 |
| Other income (expense): | Less: net income (loss) attributable to noncontrolling interests | -16,986 | -1,977 | -21,223 | 8,982 |
| Other income (expense): | Net income (loss) attributable to Baldwin | -38,995 | -3,164 | -36,654 | 10,775 |
| Other income (expense): | Basic earnings (loss) per share | -0.42 | -0.05 | -0.39 | 0.16 |
| Other income (expense): | Diluted earnings (loss) per share | -0.42 | -0.05 | -0.39 | 0.15 |
| Other income (expense): | Weighted-average shares of Class A common stock outstanding - basic | 92,761 | 68,010 | 93,278 | 67,045 |
| Other income (expense): | Weighted-average shares of Class A common stock outstanding - diluted | 92,761 | 68,010 | 93,278 | 70,393 |
| Other income (expense): | Net income (loss) | -55,981 | -5,141 | -57,877 | 19,757 |
| Other income (expense): | Other comprehensive income | 3,343 |  | 6,635 |  |
| Other income (expense): | Comprehensive income (loss) | -52,638 | -5,141 | -51,242 | 19,757 |
| Other income (expense): | Less: comprehensive income (loss) attributable to noncontrolling interests | -15,932 | -1,977 | -19,123 | 8,982 |
| Other income (expense): | Comprehensive income (loss) attributable to Baldwin | -36,706 | -3,164 | -32,119 | 10,775 |

### Income Statement (For the Three Months Ended June 30, (in thousands, except percentages))

| | For the Three Months Ended June 30, – 2026 | For the Three Months Ended June 30, – 2025 | For the Six Months Ended June 30, – 2026 | For the Six Months Ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| Revenues | 492,939 | 378,811 | 1,025,174 | 792,216 |
| Net income (loss) | -55,981 | -5,141 | -57,877 | 19,757 |
| Adjustments to net income (loss): | Amortization expense | 56,027 | 26,010 | 111,074 | 51,892 |
| Adjustments to net income (loss): | Interest expense, net(1) | 46,140 | 31,320 | 85,347 | 61,296 |
| Adjustments to net income (loss): | Share-based compensation | 20,701 | 16,952 | 33,519 | 29,755 |
| Adjustments to net income (loss): | Transaction-related partnership and integration expenses | 14,695 | 3,985 | 22,868 | 5,518 |
| Adjustments to net income (loss): | Transaction closing costs |  |  | 17,668 |  |
| Adjustments to net income (loss): | Change in fair value of contingent consideration | 12,303 | -1,957 | 14,272 | 6,104 |
| Adjustments to net income (loss): | Income and other taxes(2) | 1,084 | 1,348 | -13,064 | 2,819 |
| Adjustments to net income (loss): | Transformation costs(3) | 6,441 | 227 | 9,500 | 772 |
| Adjustments to net income (loss): | Loss on extinguishment and modification of debt | 129 |  | 7,538 | 2,394 |
| Adjustments to net income (loss): | Severance | 3,874 | 1,618 | 5,689 | 2,825 |
| Adjustments to net income (loss): | Depreciation expense | 2,773 | 1,642 | 4,804 | 3,225 |
| Adjustments to net income (loss): | Colleague earnout incentives |  | 1,490 |  | -1,779 |
| Adjustments to net income (loss): | Impairment of right-of-use assets |  | 1,188 |  | 1,188 |
| Adjustments to net income (loss): | Loss (gain) on divestitures |  | 1,111 |  | -290 |
| Adjustments to net income (loss): | Other(4) | 8,554 | 5,719 | 12,650 | 13,831 |
| Adjustments to net income (loss): | Adjusted EBITDA | 116,740 | 85,512 | 253,988 | 199,307 |
| Adjustments to net income (loss): | Net income (loss) margin | -11 | -1 | -6 | 2 |
| Adjustments to net income (loss): | Adjusted EBITDA margin | 23.7 | 22.6 | 24.8 | 25.2 |

### Income Statement (For the Three Months Ended June 30, (in thousands, except per share data))

| | For the Three Months Ended June 30, – 2026 | For the Three Months Ended June 30, – 2025 | For the Six Months Ended June 30, – 2026 | For the Six Months Ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| Net income (loss) attributable to Baldwin | -38,995 | -3,164 | -36,654 | 10,775 |
| Net income (loss) attributable to noncontrolling interests | -16,986 | -1,977 | -21,223 | 8,982 |
| Amortization expense | 56,027 | 26,010 | 111,074 | 51,892 |
| Share-based compensation | 20,701 | 16,952 | 33,519 | 29,755 |

### Balance Sheet (June 30, 2026 — (Unaudited) (in thousands, except share and per share data))

| | June 30, 2026 | December 31, 2025 |
|---|---:|---:|
| Cash and cash equivalents | 184,499 | 123,669 |
| Fiduciary cash | 426,189 | 223,228 |
| Assumed premiums, commissions and fees receivable, net | 433,617 | 342,136 |
| Fiduciary receivables | 782,194 | 497,035 |
| Prepaid expenses and other current assets | 19,592 | 13,650 |
| Total current assets | 1,846,091 | 1,199,718 |
| Property and equipment, net | 33,377 | 22,502 |
| Right-of-use assets | 81,552 | 61,976 |
| Other assets | 111,257 | 82,419 |
| Intangible assets, net | 1,450,040 | 978,434 |
| Goodwill | 2,652,407 | 1,517,171 |
| Total assets | 6,174,724 | 3,862,220 |
| Current liabilities: | Fiduciary liabilities | 1,208,383 | 720,263 |
| Current liabilities: | Commissions payable | 97,040 | 50,933 |
| Current liabilities: | Accrued expenses and other current liabilities | 294,241 | 252,560 |
| Current liabilities: | Current portion of contingent earnout liabilities | 120,901 | 9,004 |
| Current liabilities: | Total current liabilities | 1,720,565 | 1,032,760 |
| Current liabilities: | Revolving line of credit | 302,000 | 107,000 |
| Current liabilities: | Long-term debt, less current portion | 2,150,725 | 1,566,122 |
| Current liabilities: | Contingent earnout liabilities, less current portion | 225,923 | 14,289 |
| Current liabilities: | Operating lease liabilities, less current portion | 75,128 | 57,651 |
| Current liabilities: | Tax Receivable Agreement liabilities | 144,570 |  |
| Current liabilities: | Deferred tax liabilities | 4,650 |  |
| Current liabilities: | Other liabilities | 129,376 |  |
| Current liabilities: | Total liabilities | 4,752,937 | 2,777,822 |
| Mezzanine equity: | Redeemable noncontrolling interest | 614 | 519 |
| Stockholders’ equity: | Class A common stock, par value $0.01 per share, 300,000,000 shares authorized; 96,368,518 and 71,779,608 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 964 | 718 |
| Stockholders’ equity: | Class B common stock, par value $0.0001 per share, 100,000,000 shares authorized; 43,059,762 and 46,703,818 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 4 | 5 |
| Stockholders’ equity: | Additional paid-in capital | 1,246,901 | 844,236 |
| Stockholders’ equity: | Accumulated deficit | -368,468 | -245,236 |
| Stockholders’ equity: | Accumulated other comprehensive income | 5,027 | 492 |
| Stockholders’ equity: | Total stockholders’ equity attributable to Baldwin | 884,428 | 600,215 |
| Stockholders’ equity: | Noncontrolling interest | 536,745 | 483,664 |
| Stockholders’ equity: | Total stockholders’ equity | 1,421,173 | 1,083,879 |
| Stockholders’ equity: | Total liabilities, mezzanine equity and stockholders’ equity | 6,174,724 | 3,862,220 |

### Cash Flow (For the Six Months Ended June 30, — (Unaudited) (in thousands))

| | For the Six Months Ended June 30, – 2026 | For the Six Months Ended June 30, – 2025 |
|---|---:|---:|
| Net income (loss) | -57,877 | 19,757 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | Depreciation and amortization | 115,878 | 55,117 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | Change in fair value of contingent consideration | 14,272 | 6,104 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | Share-based compensation expense | 33,519 | 29,755 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | Deferred taxes | -14,873 |  |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | Payment of contingent earnout consideration in excess of purchase price accrual | -6,739 | -85,090 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | Gain on divestitures |  | -290 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | Amortization of deferred financing costs | 8,633 | 2,843 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | Other operating activity | -2,602 | 766 |
| Changes in operating assets and liabilities: | Assumed premiums, commissions and fees receivable, net | -46,138 | -53,896 |
| Changes in operating assets and liabilities: | Prepaid expenses and other current assets | -6,866 | -4,916 |

### Cash Flow (For the Three Months Ended June 30, (in thousands))

| | For the Three Months Ended June 30, – 2026 | For the Three Months Ended June 30, – 2025 | For the Six Months Ended June 30, – 2026 | For the Six Months Ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| Net cash provided by (used in) operating activities | 45,559 | -16,721 | 39,486 | -80,704 |
| Adjustments to net cash provided by (used in) operating activities: | Payment of contingent earnout consideration in excess of purchase price accrual | 863 | 6,897 | 6,739 | 85,090 |
| Adjustments to net cash provided by (used in) operating activities: | Payment of colleague earnout incentives |  | 18,462 |  | 30,061 |
| Adjustments to net cash provided by (used in) operating activities: | Adjusted free cash flow | 46,422 | 8,638 | 46,225 | 34,447 |
